Atlas Trials

Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease.

Clinical trial NCT03459521 · COMPLETED

Trial details

NCT number
NCT03459521
Sponsor
Corporacion Parc Tauli
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Liver Disease ChronicHepatitis B Virus
Start date
2017-09-01
Primary completion
2021-08-01
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.